Clinical Trial Update: Dose-Finding Study of CS19 Expressing ETEC Challenge Strains [Phase 1]

View source ↗

Summary

Phase 1 dose-finding study to evaluate CS19-expressing ETEC challenge strains for travelers' diarrhea; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Travelers Diarrhea

Drugs mentioned

• CS19 Expressing ETEC Challenge Strains

Snippet

Sponsor: Johns Hopkins Bloomberg School of Public Health | Conditions: Travelers' Diarrhea | Phase 1 | Status: COMPLETED